Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 4/2002

Content (6 Articles)

Original Article

Anti-metastatic activity of hapten-modified autologous tumor cell vaccine in an animal tumor model

Dorothy K. Sojka, Diana Felnerova, Margalit B. Mokyr

Original Article

Immunogenic regions of the GA733–2 tumour-associated antigen recognised by autoantibodies of patients with colorectal carcinoma

Szilvia Mosolits, Michael Steinitz, Ulrika Harmenberg, Ulla Ruden, Emma Eriksson, Håkan Mellstedt, Jan Fagerberg

Original Article

A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation

Naoya Hida, Yoshiaki Maeda, Kazuko Katagiri, Hideo Takasu, Mamoru Harada, Kyogo Itoh

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine